Abstract
Introduction:
A steady increase in the prevalence of obesity in patients over 50 years old has led to a growing number of laparoscopic sleeve gastrectomy (LSG) in this population. Yet the efficacy for those patients is still debated. We evaluated the impact of age on the short-term results of LSG.
Methods:
This retrospective study analyzed patients who underwent LSG between 2013 and 2020. Patients were divided into three groups: young (≤35 years, n = 35), intermediate (36–49 years, n = 58), and older age (≥50 years, n = 52). Body mass index (BMI), total weight loss (TWL), excess weight loss (EWL), and obesity-related comorbidities (ORC) were assessed 2 years after LSG.
Results:
The mean reduction in BMI, TWL, and EWL was 9.5 kg/m2, 21%–51.7% in the “older age” group, 11.9 kg/m2, 26.3%–64.6% in the “intermediate” group, and 13.3 kg/m2, 30.1%–74.4% in the “young” group, respectively. The LSG failure rate (EWL <50%) was 48.1% in the “older age” group, higher than in the “young” group (14.3%) (P = .001). The rate of remission or improvement in hypertension (HTN) was 31% in the ≥50 age group, significantly lower than in the other groups (36–49 years: 58%, ≤35 years: 100%) (P = .034). There was no significant difference between the groups in terms of other ORC. 10.5% of patients were lost to follow-up.
Conclusion:
Age appears to have a significant negative impact on weight loss results two years after LSG, with no impact on remission or improvement in ORC other than HTN.
Get full access to this article
View all access options for this article.
